Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.10 Friday, 10th May 2024 AFMD stock ended at $5.25. This is 0.287% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.28% from a day low at $5.11 to a day high of $5.33.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Oct 06, 2022 $19.90 $20.30 $19.60 $19.60 41 128
Oct 05, 2022 $21.30 $21.50 $19.85 $20.00 75 443
Oct 04, 2022 $21.70 $22.40 $21.10 $21.60 129 208
Oct 03, 2022 $20.80 $21.40 $19.90 $21.40 100 039
Sep 30, 2022 $20.30 $22.20 $20.30 $20.60 114 669
Sep 29, 2022 $21.00 $21.10 $20.00 $20.30 94 651
Sep 28, 2022 $20.10 $21.40 $20.00 $21.30 73 041
Sep 27, 2022 $19.70 $20.35 $19.30 $19.80 94 342
Sep 26, 2022 $20.00 $20.80 $19.60 $19.60 82 265
Sep 23, 2022 $19.80 $20.80 $19.50 $20.00 119 400
Sep 22, 2022 $20.40 $20.80 $19.33 $20.30 110 201
Sep 21, 2022 $21.30 $21.30 $19.85 $20.20 133 774
Sep 20, 2022 $21.60 $21.70 $20.70 $20.90 115 673
Sep 19, 2022 $22.50 $23.00 $21.55 $21.60 132 580
Sep 16, 2022 $24.50 $24.60 $21.70 $22.30 609 973
Sep 15, 2022 $25.80 $26.25 $24.50 $25.10 295 447
Sep 14, 2022 $26.40 $27.30 $25.50 $26.00 162 725
Sep 13, 2022 $26.80 $28.00 $26.40 $26.40 223 843
Sep 12, 2022 $27.50 $27.95 $26.70 $27.60 62 763
Sep 09, 2022 $27.30 $27.80 $26.90 $27.40 86 994
Sep 08, 2022 $25.60 $27.00 $25.30 $26.90 37 604
Sep 07, 2022 $24.10 $26.00 $23.80 $26.00 73 339
Sep 06, 2022 $25.10 $26.12 $24.10 $24.30 82 829
Sep 02, 2022 $27.20 $27.45 $26.00 $26.20 53 969
Sep 01, 2022 $26.30 $27.00 $25.55 $27.00 44 888
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT